Unicycive Therapeutics, Inc. (UNCY) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts UNCY Hot Sheet
Join SI Premium – FREE
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q3 EPS of ($0.37), $0.09 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $951 thousand.
For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Lowered to $25 at Guggenheim
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Unicycive Therapeutics, Inc (UNCY) Tops Q2 EPS by 42c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
